EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder

Xi Zhu iD, Chen Zhang iD, David Hellerstein, Jamie D Feusner, Michael G Wheaton, Gloria J Gomez, Franklin Schneier

Psychedelics · 2024

DOI: 10.61373/pp024r.0028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychedelics, 2024. Verfasst von Xi Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Body dysmorphic disorder (BDD) is a severe psychiatric condition characterized by preoccupation with perceived flaws in one's appearance, which the individual views as defective or ugly. Psilocybin, a serotonin 2A receptor agonist with psychedelic properties, has emerged as a potential therapeutic agent for depression and other psychiatric disorders. This study aimed to identify subacute neural changes predicting symptomatic response to psilocybin treatment in adults with BDD. Eight adults with moderate-to-severe nondelusional BDD were administered a single oral 25 mg dose of psilocybin, accompanied by psychological support, and underwent resting state functional magnetic resonance imaging assessments 1 day before and 1 day after the dosing. Both a region of interest (ROI)-to-ROI analysis and multivariate pattern analysis (MVPA) were used to identify changes in resting state functional connectivity (rsFC) at day 1 after dosing that predicted treatment response at week 1, measured by change in Yale-Brown Obsessive Compulsive Disorder Scale Modified for BDD (BDD-YBOCS) score. All participants completed the dosing and follow-up assessments over 12 weeks. BDD-YBOCS scores decreased at week 1 and week 12 after dosing ( p

Schlagwörter

Stichwörter der Autor:innen

Body dysmorphic disorderfunctional connectivitypsilocybinresting state fMRItreatment response

Autor:innen und Institutionen

  • Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
  • Anxiety Disorders Clinic, New York State Psychiatric Institute, New York, NY, USA.
  • Division of Neurosciences and Clinical Translation, University of Toronto, Toronto, Ontario, Canada.
  • Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Barnard College, Columbia University, New York, New York, USA.

ORCID-Profile: Xi Zhu, Chen Zhang

Förderung

  • NIMH NIH HHS

Zitieren

APA

Zhu, X., Zhang, C., Hellerstein, D., Feusner, J. D., Wheaton, M. G., Gomez, G. J., & Schneier, F. (2024). Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder. Psychedelics. https://doi.org/10.61373/pp024r.0028

Vancouver

Zhu X, Zhang C, Hellerstein D, Feusner JD, Wheaton MG, Gomez GJ, et al. Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder. Psychedelics. 2024. doi:10.61373/pp024r.0028

BibTeX
@article{Zhu2024,
  author = {Zhu, Xi and Zhang, Chen and Hellerstein, David and Feusner, Jamie D and Wheaton, Michael G and Gomez, Gloria J and Schneier, Franklin},
  title = {Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder},
  journal = {Psychedelics},
  year = {2024},
  doi = {10.61373/pp024r.0028}
}
Kostenlos starten →